Syncell is a life sciences technology company focused on advancing spatial proteomics through proprietary microscopy-guided protein discovery platforms. Founded in 2020, the company was established based on technology developed by founder and CEO Jung-Chi Liao at Academia Sinica in Taiwan.

The company specialises in enabling researchers to study proteins within their native biological context, addressing limitations associated with traditional proteomics methods that often lose spatial information during sample preparation. Syncell’s technology combines microscopy, photochemistry, artificial intelligence, mass spectrometry and automation to enable highly precise protein labelling and extraction from specific regions of interest within cells and tissues.

Syncell is best known for its proprietary Microscoop® platform, which allows scientists to perform microscopy-guided spatial proteomic discovery at subcellular resolution. The technology supports hypothesis-free protein discovery, enabling the identification of both known and previously undetected proteins in disease-relevant cellular environments.

Headquartered in Taipei, Taiwan, with operations in the United States, the company serves pharmaceutical companies, biotechnology organisations and academic research institutions worldwide. Its technologies are applied across fields including oncology, neuroscience, immunology, cell biology and drug discovery.

Syncell positions itself as a next-generation spatial biology company, helping researchers uncover protein interactions, disease mechanisms and potential therapeutic targets that may not be detectable using conventional proteomics approaches.

Key products and services

Microscoop® spatial proteomics platform

• Microscopy-guided protein labelling and purification
• Spatial proteomics analysis at cellular and subcellular resolution
• High-precision protein discovery within defined regions of interest (ROIs)

Spatial proteomics reagents

• Synlight™ photolabelling reagents
• Synpull™ protein enrichment reagents
• Tools designed for highly specific spatial protein capture workflows

Drug discovery and translational research support

• Target identification and validation
• Mechanism-of-action (MOA) studies
• Biomarker discovery and spatial biology analysis
• Safety and toxicity profiling using spatial proteomics approaches

Proteomics and biological research applications

• Oncology and immuno-oncology research
• Neuroscience and neurodegenerative disease studies
• Cell biology and organelle proteomics
• Disease mechanism investigation and pathway analysis

AI-enabled image and protein analysis

• AI-driven image segmentation and region selection
• Automated microscopy-guided workflows
• Integration with mass spectrometry-based proteomic analysis

By combining microscopy, artificial intelligence, photochemistry and proteomics within a single platform, Syncell is helping researchers explore protein biology with unprecedented spatial precision. Its Microscoop® technology enables unbiased discovery of proteins within specific cellular environments, supporting drug discovery, biomarker identification and translational research across a wide range of disease areas.